These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9850051)

  • 1. The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.
    Shipman CM; Croucher PI; Russell RG; Helfrich MH; Rogers MJ
    Cancer Res; 1998 Dec; 58(23):5294-7. PubMed ID: 9850051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrogen-containing bisphosphonates induce S-phase cell cycle arrest and apoptosis of myeloma cells by activating MAPK pathway and inhibiting mevalonate pathway.
    Iguchi T; Miyakawa Y; Yamamoto K; Kizaki M; Ikeda Y
    Cell Signal; 2003 Jul; 15(7):719-27. PubMed ID: 12742232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells.
    Merrell MA; Wakchoure S; Lehenkari PP; Harris KW; Selander KS
    Eur J Pharmacol; 2007 Sep; 570(1-3):27-37. PubMed ID: 17640631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell lines and primary adult T-cell leukaemia cells by interfering with the mevalonate pathway.
    Ishikawa C; Matsuda T; Okudaira T; Tomita M; Kawakami H; Tanaka Y; Masuda M; Ohshiro K; Ohta T; Mori N
    Br J Haematol; 2007 Feb; 136(3):424-32. PubMed ID: 17233845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mevastatin-induced apoptosis and growth suppression in U266 myeloma cells.
    Jánosi J; Sebestyén A; Bocsi J; Barna G; Nagy K; Vályi-Nagy I; Kopper L
    Anticancer Res; 2004; 24(3a):1817-22. PubMed ID: 15274361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
    Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
    Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
    Oades GM; Senaratne SG; Clarke IA; Kirby RS; Colston KW
    J Urol; 2003 Jul; 170(1):246-52. PubMed ID: 12796698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs.
    Coxon FP; Benford HL; Russell RG; Rogers MJ
    Mol Pharmacol; 1998 Oct; 54(4):631-8. PubMed ID: 9765505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The level of ATP analog and isopentenyl pyrophosphate correlates with zoledronic acid-induced apoptosis in cancer cells in vitro.
    Mitrofan LM; Pelkonen J; Mönkkönen J
    Bone; 2009 Dec; 45(6):1153-60. PubMed ID: 19699819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mevalonate/isoprenoid pathway inhibitor apomine (SR-45023A) is antiproliferative and induces apoptosis similar to farnesol.
    Flach J; Antoni I; Villemin P; Bentzen CL; Niesor EJ
    Biochem Biophys Res Commun; 2000 Apr; 270(1):240-6. PubMed ID: 10733934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoledronate has an antitumor effect and induces actin rearrangement in dexamethasone-resistant myeloma cells.
    Koizumi M; Nakaseko C; Ohwada C; Takeuchi M; Ozawa S; Shimizu N; Cho R; Nishimura M; Saito Y
    Eur J Haematol; 2007 Nov; 79(5):382-91. PubMed ID: 17903213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells.
    Morgan MA; Sebil T; Aydilek E; Peest D; Ganser A; Reuter CW
    Br J Haematol; 2005 Sep; 130(6):912-25. PubMed ID: 16156861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.
    Virtanen SS; Väänänen HK; Härkönen PL; Lakkakorpi PT
    Cancer Res; 2002 May; 62(9):2708-14. PubMed ID: 11980672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mevastatin induced apoptosis in U266 human myeloma cell line].
    Jánosi J; Sebestyén A; Bocsi J; Barna G; Nagy K; Vályi-Nagy I; Kopper L
    Magy Onkol; 2004; 48(4):333-7. PubMed ID: 15655579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the mevalonate pathway potentiates the effects of lenalidomide in myeloma.
    van der Spek E; Bloem AC; Lokhorst HM; van Kessel B; Bogers-Boer L; van de Donk NW
    Leuk Res; 2009 Jan; 33(1):100-8. PubMed ID: 18621417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins prevent bisphosphonate-induced gamma,delta-T-cell proliferation and activation in vitro.
    Thompson K; Rogers MJ
    J Bone Miner Res; 2004 Feb; 19(2):278-88. PubMed ID: 14969398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pamidronate inhibits antiapoptotic bcl-2 expression through inhibition of the mevalonate pathway in prostate cancer PC-3 cells.
    Iguchi K; Tatsuda Y; Usui S; Hirano K
    Eur J Pharmacol; 2010 Sep; 641(1):35-40. PubMed ID: 20519142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
    Cuthbert JA; Lipsky PE
    Cancer Res; 1997 Aug; 57(16):3498-505. PubMed ID: 9270019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological control of the mevalonate pathway: effect on arterial smooth muscle cell proliferation.
    Raiteri M; Arnaboldi L; McGeady P; Gelb MH; Verri D; Tagliabue C; Quarato P; Ferraboschi P; Santaniello E; Paoletti R; Fumagalli R; Corsini A
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1144-53. PubMed ID: 9190847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
    Moriceau G; Roelofs AJ; Brion R; Redini F; Ebetion FH; Rogers MJ; Heymann D
    Cancer; 2012 Feb; 118(3):750-60. PubMed ID: 21751201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.